News Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			Pre-market 08:13:54 am
43.02 ^USD	-1.62%		42.82	-0.45%

May. 21	QIAGEN NV : Berenberg maintains a Buy rating	ZD
May. 15	Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QIAGEN NV : Berenberg maintains a Buy rating	May. 21	ZD
Qiagen's Updated Clinical Decision Support Platform Secures EU Certification	May. 15	MT
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support	May. 14	AQ
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret	May. 14	CI
Qiagen N : 2023 Annual Report 2023 Sustainability Statement	May. 13	PU
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test	May. 13	MT
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel	May. 13	MT
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results	May. 13	AQ
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation	May. 08	PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report	May. 08	PU
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics	May. 08	MT
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics	May. 07	AQ
QIAGEN Partners with FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics	May. 07	CI
Qiagen N : Q1 2024 Results Investor Introduction	May. 03	PU
Qiagen N : Virtual Berenberg MDx Day Investor Introduction	May. 02	PU
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications	May. 02	AQ
QIAGEN Announces the Availability of QCI Secondary Analysis	May. 02	CI
Qiagen N : First Quarter 2024 SEC Filing	May. 02	PU
QIAGEN NV : Berenberg reaffirms its Buy rating	Apr. 30	ZD
QIAGEN : A decent start to 2024; guidance unchanged	Apr. 30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

QIAGEN : A decent start to 2024; guidance unchanged

April 30, 2024 at 09:32 am EDT